O-Cyanobenzaldehydes (CNBA) Irreversibly Modify both Bur-ied and Exposed Lysine Residues in Live Cells
Ontology highlight
ABSTRACT: Lysine residue represents an attractive site for covalent drug development due to high abundance (5.6%) and critical functions. However, very few lysines have been characterized to be accessible to covalent ligands and perturb the protein functions, owning to their protonation state and adjacent steric hindrance. Herein, we report a new lysine bioconjugation chemistry, O-Cyanobenzaldehydes (CNBA), that enables selective modification of the lysine ε-amine to form iso-indolinones under physiological conditions. Proteome profiling enabled the mapping of 85 endogenous kinases in live cells, highlighting its potential for modifying buried catalytic lysines within the kinome. Further protein crystallography and mass spectrometry confirmed that K271_ABL1 and K162_AURKA are covalently targetable sites in kinases. Leverag-ing a structure-based drug design (SBDD), we incorporated CNBA into the core structure of Nutlin-3 to irreversibly inhibit MDM2-p53 interaction by targeting an exposed lysine K94 on the surface of MDM2. Importantly, we have demonstrated the potential application of CNBA as a lysine-recognized bioconjugation agent for developing new Antibody-drug conju-gates (ADCs). The results collectively validate CNBA as a new selective and efficient modifying agent with broad applica-tions for both buried and exposed lysine residues in live cells.
INSTRUMENT(S): Q Exactive HF-X
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): T Cell, Cell Culture
SUBMITTER:
Jiangnan Zheng
LAB HEAD: Ruijun Tian
PROVIDER: PXD060708 | Pride | 2025-03-27
REPOSITORIES: Pride
ACCESS DATA